Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Sickle cell pain: Opioids appear safe for inpatients

Akinboro OA et al. ASH 2018, Abstract 315

Key clinical point: Sickle cell disease patients appear to be at lower risk for opioid-related mortality than the general U.S. population.

Major finding: While the rate of inpatient death from opioid overdose rose 350% among the general U.S. population from 1998 to 2013, it remained essentially at zero among patients with sickle cell disease.

Study details: A retrospective analysis of discharge diagnoses from the National Inpatient Sample from 1998 to 2013.

Disclosures: The researchers reported having no relevant financial disclosures.

Read the article here.


Akinboro OA et al. ASH 2018, Abstract 315.